Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189917
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2005-09-11
Brief Title:
Safety Tolerability and Immune Response of IMVAMUNE MVA-BNSmallpox Vaccine in Patients With Atopic Disorders
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
ACTUAL
Primary Completion Date:
2005-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-09-11
First Submit QC Date:
September 11 2005
Study First Post Date:
2005-09-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-08
Last Update Post Date:
2019-01-10
Last Update Post Date Type:
ACTUAL